11.+Immune+Respone+to+Cancer+1+slide

Cd 19 is associated with b cells leukemia is b cell

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: ells. leukemia is B cell cancer. N Engl J Med Volume 365(8):725-733 August 25, 2011 Study Overview leukemia •  A patient with refractory CLL had delayed development of the rapid tumor lysis syndrome and remission after an infusion of T cells engineered to express an antigen receptor capable of recognizing B cells (CD19) coupled to two signaling molecules. outcome of patient- ten months later still in remission. No B cells and hypoExpansion and Persistence of Chimeric Antigen Receptor T Cells In Vivo. gammaglobinemia are both seen ten months after treatment. CD5 another molecules B cells most B cells use kapa mostely killed the B cells. it would decrease and thus immunosuppressant. risk benefit Transfer pooled gammaglobulin that would cover wide range of microgobulins. most b cells have kapa bcells with kapa light chain. doesnt have antibodies Porter DL et al. N Engl J Med 2011;365:725-733 Prostate Cancer Treatment With Sipuleucel-T and it contains GM-CSF A chimeric protein containing GM-CSF [activates APCs] plus Prostatic Acid Phosphatase [PAP] was transfected only be presented as class 1 into DCs. The median survival time with sipuleucel-T was 25.8 months compared to 21.7 months for control group. There was no difference in tumor progression! Melanoma- gp 100 or glycoprotein 100 * class 1 gene. Melanoma patients with an HLA allele called A 0201 are given a peptide intramuscularly that consists of nine amino acids (209-217 or 280-288) from MAGE (melanoma associated antigen) glycoprotein. May also receive simultaneously interleukin 2, an immune stimulatory molecule. Drawback is patients must have inherited correct HLA allele for this particular “vaccine” to work. Various reports* indicate that one year survival with gp100 is minimally different from control patients. *Rosenberg SA et al, Nat Med 2004; 10:909-915. Use of monoclonal antibodies in cancer immune therapy -mab is a monoclonal antibody prevents shutting down Ipilimumab (brand name is yervoy)-an antibody that blocks CTLA-4, a molecule expressed by T cells. Tregs Blocking of cytotoxic T- ly...
View Full Document

This document was uploaded on 03/10/2014 for the course BIOLOGY 104 at Tufts.

Ask a homework question - tutors are online